nadp has been researched along with Diabetic Glomerulosclerosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Hu, Y; Li, L; Liu, D; Lu, Z; Ma, H; Sun, F; Tepel, M; Wang, L; Wei, X; Yan, Z; Yang, G; Zhang, H; Zheng, H; Zhu, Z | 1 |
| Chang, YK; Choi, DE; Choi, DH; Choi, H; Hwang, JH; Jeong, JY; Kim, JH; Lee, CH; Lee, KW; Moon, SJ; Na, KR | 1 |
| Cooper, ME; Coughlan, MT; Elbatreek, MH; Granata, C; Harris, DCH; Jandeleit-Dahm, K; Jha, JC; Kantharidis, P; Laskowski, A; Lindblom, RS; Rubera, I; Shah, AM; Snelson, M; Sourris, KC; Tan, SM; Tauc, M; Thallas-Bonke, V; Watson, A; Zheng, G | 1 |
| Dai, X; Duan, JA; Qian, D; Shang, EX; Su, S; Wang, Q; Wei, D; Xiang, X; Xu, Z; Zheng, T | 1 |
| Chen, X; Cheung, WW; Huang, R; Ji, X; Lan, T; Li, C; Li, N; Liu, B; Ou, Y; Wang, L; Yang, G; Yang, Z; Yuan, K | 1 |
| Spencer, NY; Stanton, RC | 1 |
| Bryla, J; Dudziak, M; Gorniak, P; Szymanski, K; Winiarska, K | 1 |
| Choi, MS; Ha, SO; Huh, TL; Jeon, SM; Kim, K; Koh, HJ; Kwon, OS; Lee, SH | 1 |
| Lopes de Faria, JB; Lopes de Faria, JM; Papadimitriou, A; Peixoto, EB; Pessôa, BS | 1 |
| Alvares-Aguilar, C; Medina-Navarro, R; Nieto-Aguilar, R | 1 |
1 review(s) available for nadp and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Glucose 6-phosphate dehydrogenase and the kidney.
Topics: Diabetes Mellitus; Diabetic Nephropathies; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Humans; Kidney; Kidney Diseases; NADP; Nitric Oxide; Pentose Phosphate Pathway | 2017 |
9 other study(ies) available for nadp and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Reducing NADPH Synthesis Counteracts Diabetic Nephropathy through Restoration of AMPK Activity in Type 1 Diabetic Rats.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; NADP; Rats; Signal Transduction | 2020 |
The potential roles of NAD(P)H:quinone oxidoreductase 1 in the development of diabetic nephropathy and actin polymerization.
Topics: Actins; Animals; Cells, Cultured; Diabetic Nephropathies; Disease Models, Animal; Humans; Kidney Glomerulus; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD(P)H Dehydrogenase (Quinone); NADP; Polymerization; Streptozocin | 2020 |
Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Tubules; Kidney Tubules, Proximal; Mice; NADP; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species | 2021 |
A natural product of acteoside ameliorate kidney injury in diabetes db/db mice and HK-2 cells via regulating NADPH/oxidase-TGF-β/Smad signaling pathway.
Topics: Animals; Biological Products; Cell Line; Diabetes Mellitus; Diabetic Nephropathies; Glucosides; Humans; Kidney; Male; Mice; NADP; NADPH Oxidases; Phenols; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2021 |
Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Topics: Animals; Cell Nucleus; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Diterpenes; DNA; Extracellular Matrix; Glucose; Humans; Hyperglycemia; Hypertrophy; Inflammation; Kidney; Kidney Glomerulus; Male; Mesangial Cells; Mice, Inbred C57BL; NADP; NF-kappa B; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Streptozocin | 2016 |
Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits.
Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Catalase; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gluconeogenesis; Glutamate-Cysteine Ligase; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Glutathione Reductase; Hypoglycemic Agents; Kidney Cortex; Male; NADP; Oxidation-Reduction; Oxidative Stress; Rabbits; Superoxide Dismutase; Superoxides; Taurine; Urea | 2009 |
Upregulation of cytosolic NADP+-dependent isocitrate dehydrogenase by hyperglycemia protects renal cells against oxidative stress.
Topics: Animals; Cell Line; Cytoprotection; Cytosol; Diabetic Nephropathies; Dogs; Enzyme Induction; Glucose; Humans; Hyperglycemia; Isocitrate Dehydrogenase; Kidney Tubules, Proximal; Male; Mice; NADP; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stress, Physiological; Transfection; Up-Regulation | 2010 |
Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.
Topics: Animals; Antioxidants; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA Damage; Glucosephosphate Dehydrogenase; Glutathione Disulfide; Humans; Immediate-Early Proteins; Kidney Cortex; Lipid Peroxidation; Mesangial Cells; Mineralocorticoid Receptor Antagonists; Models, Biological; NADP; NADPH Oxidases; Oxidants; Oxidative Stress; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; Spironolactone; Superoxides; Up-Regulation | 2012 |
Protein conjugated with aldehydes derived from lipid peroxidation as an independent parameter of the carbonyl stress in the kidney damage.
Topics: Acrolein; Aldehydes; Animals; Blood Proteins; Case-Control Studies; Diabetic Nephropathies; Humans; Kinetics; Lipid Peroxidation; Liver; Male; Microsomes; NADP; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Reference Standards; Serum Albumin; Spectrophotometry | 2011 |